ALX Oncology Holdings Inc.
ALXO
$2.19
$0.041.86%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -101.70M | -108.01M | -116.57M | -130.02M | -134.85M |
| Total Depreciation and Amortization | 706.00K | 769.00K | 840.00K | 869.00K | 872.00K |
| Total Amortization of Deferred Charges | 280.00K | 277.00K | 271.00K | 268.00K | 265.00K |
| Total Other Non-Cash Items | 16.23M | 18.92M | 22.58M | 23.46M | 24.23M |
| Change in Net Operating Assets | 336.00K | -9.16M | -12.61M | -3.23M | -12.43M |
| Cash from Operations | -84.14M | -97.21M | -105.49M | -108.65M | -121.91M |
| Capital Expenditure | -212.00K | -223.00K | -316.00K | -359.00K | -447.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 82.80M | 104.76M | 109.15M | 87.79M | 86.70M |
| Cash from Investing | 82.59M | 104.54M | 108.84M | 87.43M | 86.26M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.36M | -780.00K | -978.00K | -959.00K | -827.00K |
| Issuance of Common Stock | 38.00K | 61.00K | 594.00K | 1.75M | 1.98M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.69M | 731.00K | 806.00K | 27.01M | 29.66M |
| Cash from Financing | 362.00K | 12.00K | 422.00K | 27.80M | 30.82M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.19M | 7.34M | 3.77M | 6.57M | -4.84M |